Interdisciplinary multimodality management of stage III nonsmall cell lung cancer

Stage III nonsmall cell lung cancer (NSCLC) comprises about one-third of NSCLC patients and is very heterogeneous with varying and mostly poor prognosis. It is also called “locoregionally or locally advanced disease”. Due to its heterogeneity a general schematic management approach is not appropriat...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Rudolf M., De Ruysscher, Dirk, Hoffmann, Hans, Reu, Simone, Tufman, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488854/
https://www.ncbi.nlm.nih.gov/pubmed/31285288
http://dx.doi.org/10.1183/16000617.0024-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9488854/
https://www.ncbi.nlm.nih.gov/pubmed/31285288
http://dx.doi.org/10.1183/16000617.0024-2019

Ejemplares similares